<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170411033378N11</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-18</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of group cognitive behavioral therapy on mood symptoms and temptation to substance use.</public_title>
      <acronym>GCBT</acronym>
      <scientific_title>The effect of group cognitive behavioral therapy on mood symptoms and temptation to substance use in male patients with bipolar disorder and substance dependence.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-06-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69974</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Factorial, Purpose: Education/Guidance, Randomization description: The sampling method in this research is block randomization method. In this method, patients who meet the study entry criteria are divided equally and randomly into two intervention and control groups. For this purpose, blocks have been formed, within each block, half of the patients are placed in the intervention group and half of them are included in the control group. The main goal in this method is to balance the number of participants in each group. Considering that it is difficult to conduct group therapy for more than ten patients, and we have two intervention groups of ten, four blocks of ten are prepared. In each of these blocks, 5 patients are randomly placed in the intervention group (A) and 5 patients in the control group (B). The randomization sequence is provided through the following website: https://www.sealedenvelope.com/simple-randomiser/v1/lists, Blinding description: Due to the clarity of the intervention received by the members of the groups involved in the study, it is practically impossible to blind the study participants.Therefore, in order to blind and prevent bias in all stages, completing the questionnaires and analyzing the data are done by people who do not know whether the patients are in the intervention group or the control group (People other than cognitive behavioral therapists).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Bipolar disorder. Condition 2: Substance dependence.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: the intervention group includes 2 closed groups of 10 people (due to the limitation in the number of people present in the therapy group). For these people, in addition to the usual care, group cognitive behavioral therapy sessions are held for 8 sessions, two sessions a week, in the evenings in the classrooms in the psychiatry departments by a trained psychiatric nursing student and with the presence of the psychiatric nursing faculty experienced in this field. Each session will last 1.5 hours and about 10 minutes between sessions will be considered for rest and a short reception. Sessions are systematic with specific content and specific assignments for patients. Intervention 2: Control group: does not receive intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
IPD briefly describe what specific participant data sets are to be shared

When:
Starting in Oct 2023

To whom:
People working in academic institutions

Conditions:
People working in academic institutions

Where to obtain:
Via Email: sadeghianefat@gmail.com

How to obtain:
Via Email: sadeghianefat@gmail.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Efat Sadeghian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hamadan University of Medical Sciences, Shahid Fahmideh Blvd.</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6861819453</zip>
        <telephone>6517838736</telephone>
        <email>sadeghianefat@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Efat Sadeghian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hamedan University of Medical Sciences, In front of Mardom Park</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517838698</zip>
        <telephone>+98 81 3838 0150</telephone>
        <email>sadeghianefat@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The diagnosis of bipolar disorder has been confirmed by a psychiatrist
Have drug dependence
Ability to communicate and answer questionnaires
Being literate in reading and writing
Consent to participate in the study
Receive usual medical care and treatment
Not having a physical or mental disability
Not  having another psychiatric disorder along with bipolar disorder
Not participating in similar psychotherapy</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Entering the acute phase of the disease
Absence in more than 2 sessions of group therapy sessions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F31.9</hc_code>
      <hc_code>F19.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Bipolar affective disorder, unspecified</hc_keyword>
      <hc_keyword>Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: the intervention group includes 2 closed groups of 10 people (due to the limitation in the number of people present in the therapy group). For these people, in addition to the usual care, group cognitive behavioral therapy sessions are held for 8 sessions, two sessions a week, in the evenings in the classrooms in the psychiatry departments by a trained psychiatric nursing student and with the presence of the psychiatric nursing faculty experienced in this field. Each session will last 1.5 hours and about 10 minutes between sessions will be considered for rest and a short reception. Sessions are systematic with specific content and specific assignments for patients.</i_keyword>
      <i_keyword>Control group: does not receive intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mania score in Hirschfeld Mood Disorder Questionnaire (2000). Timepoint: Measuring the mania score at the beginning of the study (before the start of the intervention), after the completion of the group cognitive behavioral therapy sessions, one month and three months after the completion of the sessions. Method of measurement: Hirschfeld Mood Disorder Questionnaire (2000).</prim_outcome>
      <prim_outcome>Depression score in Beck Depression Questionnaire (short form with 13 questions). Timepoint: Measuring the Depression score at the beginning of the study (before the start of the intervention), after the completion of the group cognitive behavioral therapy sessions, one month and three months after the completion of the sessions. Method of measurement: Depression Questionnaire (short form with 13 questions).</prim_outcome>
      <prim_outcome>Temptation score in Wright's Craving Beliefs Questionnaire (2003). Timepoint: Measuring the temptation score at the beginning of the study (before the start of the intervention), after the completion of the group cognitive behavioral therapy sessions, one month and three months after the completion of the sessions. Method of measurement: Wright's Craving Beliefs Questionnaire (2003).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamadan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-04-29</approval_date>
        <contact_name>Ethics committee of Hamadan University of Medical</contact_name>
        <contact_address>In front of Mardom Park, Hamedan University of Medical Sciences, Hamadan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
